Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hypersensitivity Reactions: Cytolytic Reactions

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus.

Proteomics·2026

Same author

Dual-beam differential optical imaging for atmospheric turbulence mitigation in free-space propagation.

Optics express·2026

Same author

Revisiting oat composition, functional and thermal properties, and processing strategies for enhanced nutritional and functional performance.

Journal of the science of food and agriculture·2026

Same author

Emerging role of antibody-drug conjugates in gastrointestinal malignancies.

Cancer·2026

Same author

Structure-Activity Relationship Studies for 1,3,4-Thiadiazole-Based Bacterial Carbonic Anhydrase Inhibitors with <i>In Vivo</i> Efficacy against Drug-Resistant <i>Neisseria gonorrhoeae</i>.

Journal of medicinal chemistry·2026

Same author

Workflow for removal of dislodged leadless pacemaker from distal pulmonary artery: A case report.

HeartRhythm case reports·2026

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Immunotherapy-associated autoimmune hemolytic anemia.

Uqba Khan^1,2, Farman Ali¹, Muhammad Siddique Khurram¹

¹Graduate Medical Education, St. John Hospital and Medical Center, Detroit, MI USA.

Journal for Immunotherapy of Cancer

|February 28, 2017

Summary

Combined immunotherapy with ipilimumab and nivolumab can cause severe autoimmune hemolytic anemia. Early recognition and treatment with steroids and rituximab are crucial for managing this rare but serious side effect in melanoma patients.

Keywords:

Autoimmune hemolytic anemia Immunotherapy Ipilimumab Nivolumab

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Mar 7, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

Area of Science:

Oncology
Immunology
Hematology

Background:

Cancer immunotherapy, particularly with checkpoint inhibitors targeting CTLA-4 and PD-1 pathways, has transformed malignancy treatment.
Combined CTLA-4 and PD-1 inhibition offers synergistic efficacy but increases the risk of toxicity.
Metastatic melanoma is a key indication for these advanced immunotherapeutic strategies.

Observation:

A 43-year-old woman with metastatic melanoma developed severe autoimmune hemolytic anemia after two cycles of ipilimumab and nivolumab.
Clinical presentation included severe anemia, elevated lactate dehydrogenase, absent haptoglobin, and a positive direct Coombs test.
The patient's symptoms manifested three weeks after her last immunotherapy administration.

Findings:

The patient was diagnosed with severe autoimmune hemolytic anemia directly linked to ipilimumab and nivolumab treatment.
Successful management was achieved using high-dose steroids and rituximab.
This case highlights an unusual and severe adverse event associated with combined immunotherapy.

Implications:

Healthcare professionals must be aware of rare but potentially lethal adverse effects of cancer immunotherapies.
Early identification and prompt management of immunotherapy-induced autoimmune hemolytic anemia are critical for patient outcomes.
Understanding these side effects is essential for the safe and effective application of revolutionary cancer treatments.